Future Medicine Co., Ltd. (XKON:341170)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,265.00
-75.00 (-5.60%)
At close: Oct 24, 2025
-5.60%
Market Cap11.58B
Revenue (ttm)1.00B
Net Income (ttm)-13.37B
Shares Out9.28M
EPS (ttm)-1,637.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,856
Average Volume2,856
Open1,299.00
Previous Close1,340.00
Day's Range1,200.00 - 1,395.00
52-Week Range680.00 - 2,800.00
Beta-0.05
RSI35.96
Earnings Daten/a

About Future Medicine

Future Medicine Co., Ltd. operates as a drug development company worldwide. It develops drugs for use in the treatment of fibrosis and inflammation in non-alcoholic steatohepatitis, chronic kidney disease, glaucoma, and primary biliary cirrhosis; colorectal, prostate, and lung cancer; and COVID-19 and rheumatoid arthritis/atopy. The company was founded in 2015 and is based in Seongnam, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 26
Stock Exchange Korea New Exchange
Ticker Symbol 341170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.